Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 60.84M | 69.85M | 78.44M | 74.48M | 87.28M | 185.69M |
Gross Profit | 6.60M | 14.48M | 24.34M | 31.49M | 39.26M | 69.08M |
EBITDA | -3.08M | -2.75M | -3.06M | -10.88M | 2.09M | -9.06M |
Net Income | -5.35M | -4.68M | -6.01M | -25.38M | -66.15M | -60.35M |
Balance Sheet | ||||||
Total Assets | 47.95M | 48.38M | 33.42M | 44.68M | 50.73M | 146.10M |
Cash, Cash Equivalents and Short-Term Investments | 15.61M | 4.37M | 1.37M | 19.68M | 3.42M | 35.25M |
Total Debt | 13.13M | 11.73M | 12.43M | 16.79M | 21.54M | 110.03M |
Total Liabilities | 44.09M | 42.61M | 22.97M | 28.23M | 73.35M | 136.32M |
Stockholders Equity | 3.86M | 5.76M | 10.45M | 16.46M | -22.62M | 9.78M |
Cash Flow | ||||||
Free Cash Flow | 9.62M | 4.20M | -16.73M | -32.35M | -5.84M | 13.07M |
Operating Cash Flow | 9.62M | 4.20M | -14.58M | -28.96M | -5.12M | 14.29M |
Investing Cash Flow | 0.00 | 1.00K | -2.15M | -2.47M | 56.96M | -1.01M |
Financing Cash Flow | -1.21M | -1.21M | -1.58M | 47.68M | -52.89M | -16.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $189.81B | 12.67 | 8.56% | 3.73% | 3.95% | -6.94% | |
71 Outperform | $10.14B | 7.72 | 4.75% | 3.81% | 4.24% | 25.30% | |
68 Neutral | €22.00B | 35.61 | 42.24% | 2.55% | -5.88% | -18.17% | |
57 Neutral | HK$397.42M | ― | -3.04% | 13.33% | -21.53% | -131.69% | |
54 Neutral | $1.19B | 3.63 | 0.13% | 7.02% | -2.13% | -128.06% | |
39 Underperform | HK$41.64M | ― | -146.45% | ― | -24.83% | -6.70% | |
39 Underperform | HK$238.51M | ― | -335.55% | ― | -19.47% | 67.26% |